The bearish market that led Lombard Medical to delay its IPO and TriVascular Technologies ($TRIV) to price below its range has scuttled a fundraise from diagnostics luminary Foundation Medicine ($FMI). The company pulled the plug on an effort to raise $150 million in a stock offering, citing "market conditions" in a filing with the SEC. The company raised $106 million in its IPO last year, and its shares are up about 44% since then. Filing | Initial S-1